Stallergenes Greer Ltd - Strategic SWOT Analysis Review

Stallergenes Greer Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company’s operations and business divisions
• Corporate strategy - The publisher's summarization of the company’s business strategy
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats
• Company history - Progression of key events associated with the company
• Major products and services - A list of major products, services and brands of the company
• Key competitors - A list of key competitors to the company
• Key employees - A list of the key executives of the company
• Executive biographies - A brief summary of the executives’ employment history
• Key operational heads - A list of personnel heading key departments/functions
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details

Highlights

Stallergenes Greer Ltd (Stallergenes Greer), a subsidiary of Waypoint Capital Holdings (Jersey) Ltd, is a biopharmaceutical company. It provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Africa; Europe, Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.

Stallergenes Greer Ltd Key Recent Developments

• Apr 26, 2023: Stallergenes Greer Foundation to Foster Innovation and Precision Medicine in the Field of Allergy
• Jul 02, 2022: Positive results of EfficAPSI real-world study confirm significant benefit of sublingual liquid AIT treatment on the onset and worsening of asthma in patients with allergic rhinitis

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy
• Understand and respond to your competitors’ business structure and strategies with the publisher's detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance

Note: Some sections may be missing if data is unavailable for the company.